NR

Nitaben Rajendrabhai Prajapati

Active Director Designated Partner DIN 09461419
DIN 09461419 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Nitaben Rajendrabhai Prajapati

Data last updated:

Nitaben Rajendrabhai Prajapati is a Designated Partner at Mahisri Hospital Llp (since 2022). The company operates in Healthcare.

DIN 09461419
Primary Designation Designated Partner
Industry Healthcare
First Appointment 07 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Jan 20222022Active

Board colleagues of Nitaben Rajendrabhai Prajapati

NameDINCompanyDesignation
Rajendra Ranchhodbhai Prajapati09461418Mahisri Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mahisri Hospital Llp
Premium access

Shareholding and investment profile for Nitaben Rajendrabhai Prajapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitaben Rajendrabhai Prajapati

Nitaben Rajendrabhai Prajapati currently holds 1 directorship: Mahisri Hospital Llp (Designated Partner, since 07 Jan 2022).

Nitaben Rajendrabhai Prajapati was first appointed on 07 Jan 2022 as Designated Partner at Mahisri Hospital Llp.

The current boards of Nitaben Rajendrabhai Prajapati's companies include Rajendra Ranchhodbhai Prajapati (Mahisri Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available